PACB

Pacific Biosciences of California, Inc.
Data: 2026-05-08
$1.41
Price
-14.55%
Change
$2.73
52W High
$0.85
52W Low

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Quick Stats
May 08, 2026

47.8

AI Score

HOLD

1.55

Volume Ratio

May 07, 2026

Next Earnings

16

+ve Days (30d)

13

-ve Days (30d)

PACB Stock Summary

Last updated May 08, 2026

PACB is currently trading at $1.41, positioned below its 200-day moving average of $1.68, suggesting bearish momentum. The stock has a 52-week range of $0.8511 to $2.73.

Technical Analysis: The 50-day moving average stands at $1.48, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.81, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.094, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates PACB at 47.8/100 with a HOLD recommendation.

PACB (Pacific Biosciences of California, Inc.) Indicators

Last updated May 08, 2026

Indicator Value
RSI(14) 41.81
CMF (20) 0.094
ROC (10) -9.615
ADX (14) 18.774
Indicator Value
MACD (12,26,9) 0.017
AROONOSC (14) -92.857
WILLAMS %R (14) -86.667
MFI (14) 43.07
PACB Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

PACB Price vs Max Options Open Interest
PACB Max Change In Options Open Interest

PACB Options - Sort by Max open Interest (near term)

8th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PACB Daily Out of Money Options - Sort by Max open Interest (near term)

8th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PACB Daily In the Money Options - Sort by Max open Interest (near term)

8th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PACB Most Active Options by Volume(near term)

8th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Pacific Biosciences of California, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

PACB Moving Averages Analysis

PACB (Pacific Biosciences of California, Inc.) Simple Moving Averages

Moving Averages are last updated May 08, 2026

Days MA
10 1.57
20 1.6
30 1.52
50 1.48
100 1.73
200 1.68

PACB Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 512.3 million
Earnings/Share ($) -1.82
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.5079
EPS Estimate Next Year ($) -0.4178
WallStreet Target Price ($) 2.375
Most Recent Quarter